Retraction Watch

Tracking retractions as a window into the scientific process

Archive for the ‘Geriatric medicine’ Category

Two more retractions bring bone researcher’s total to 12

without comments

jbmrA bone researcher based in Japan with 10 retractions under his belt has retracted two more papers for similar reasons — problems with the underlying data, and including co-authors who didn’t participate in the project.

In both notices, Yoshihiro Sato is pegged as responsible for the content of the papers. The newly retracted research covers a long timespan — one paper was published in 2000, the other in 2013.

Here’s the first notice, issued by the Journal of Bone and Mineral ResearchRead the rest of this entry »

Second retraction for bone researcher with lifetime funding ban

without comments

via WCH

via WCH

A researcher banned from funding by a Canadian agency for misconduct has earned her second retraction, after a reanalysis uncovered problems with the paper’s conclusions.

The retraction follows an investigation by Sophie Jamal‘s former workplace, the Women’s College Hospital in Toronto, which has led to a recent retraction of a JAMA paper due to data manipulation, and a lifetime funding ban from the Canadian Institutes of Health Research (CIHR).

The latest retraction stemmed from a re-analysis of the paper by the Canadian Multicentre Osteoporosis Study Group, of which the paper was a part; all authors but Jamal have requested the retraction. In the notice, the authors say that they believe no patients were harmed as a result of the “possibly invalid conclusions” in the paper, which showed patients with kidney problems were at higher risk of bone loss. A researcher told us a third paper by Jamal is also due to be retracted soon.

Here’s the retraction notice, issued by the American Journal of Kidney Diseases (AJKD): Read the rest of this entry »

You’ve been dupe’d: Results so nice, journals published them twice

without comments

With so many retraction notices pouring in, from time to time we compile a handful of straight-forward retractions.

Once again, this list focuses on duplications — but unlike other duplications, these authors were not at fault. Rather, these retractions occurred because the publishers mistakenly published the same paper twice — the result of a transfer between publishers, for instance, or accidentally publishing the unedited version of the paper. We’re forced to wonder, as we have before, whether saddling researchers’ CVs with a retraction is really the most fair way to handle these cases.

So without further ado, here’s five cases where the journal mistakenly duplicated a paper, and had to retract one version: Read the rest of this entry »

Bone researcher up to 10 retractions

with one comment

Neurology JournalA journal is retracting three papers and a letter from a bone researcher who admitted to scientific misconduct, noting that all co-authors were included only for honorary reasons.

We’ve previously reported on six retractions of papers co-authored by Yoshihiro Sato, who is based at Mitate Hospital in Japan, including one in JAMA. Retractions stemmed from the use of “honorary” co-authors, as well as concerns over the data. One paper seemed to be the victim of “extensive self-plagiarism.”

Sato, who is the first and corresponding author of all ten retractions (including the letter), accepted full responsibility of the newly retracted publications, noting that none of the co-authors took part in any misconduct.

Here’s the retraction notice — which is similar for all four new retractions — issued on July 12: Read the rest of this entry »

Against authors’ wishes, journal pulls study with errors, statistical mistake

with 3 comments

Annals of the Rheumatic DiseasesA rheumatology journal has retracted a paper about treating knee pain after an institutional investigation found a mistake in the statistical process.

Over several months, the authors proposed a series of corrections to the 2014 study. However, the journal Annals of the Rheumatic Diseases (ARD) decided that there were “unresolved concerns” about the reliability of the data, and decided to retract the paper entirely, despite the authors’ objections.

Here’s the retraction notice: Read the rest of this entry »

Canada funding agency bans researcher for fraud, and in first, reveals her name

with 5 comments

via WCH

via WCH

The Canadian Institutes of Health Research (CIHR) has banned a bone researcher for life following a finding of misconduct. And in a first, the agency has named her, in their report out today.

The case of Sophie Jamal may be familiar to Retraction Watch readers, as we covered it in October of last year following reporting by The Toronto Star. JAMA retracted a 2011 study by Jamal and colleagues in December, as we reported, and she resigned her positions at Women’s College Hospital (WCH) and the University of Toronto.

Jamal, according to the an investigating committee at WCH: Read the rest of this entry »

Written by Ivan Oransky

July 19th, 2016 at 8:30 pm

Sixth retraction appears for bone researcher due to “extensive self-plagiarism”

with 2 comments

cov150hA bone researcher in Japan has logged his sixth retraction, after acknowledging he duplicated substantial portions of a 2011 paper and added “honorary” co-authors.

The retraction, in Parkinsonism & Related Disorders, follows five others for Yoshihiro Sato, including one from JAMA, some of which were pulled over concerns regarding authorship and data integrity. The latest retraction duplicated text from another 2005 paper that was itself retracted last year, both for duplicating from this newly retracted paper and for “concerns about the underlying data.”

Sato — who is listed at Mitate Hospital on the paper — told the journal he takes full responsibility.

Here’s the retraction notice: Read the rest of this entry »

“All co-authors are honorary:” Team earns fifth retraction

with 4 comments

Movement DisordersA team of researchers from Japan has earned a fifth retraction, after co-authors told the journal that they did not participate in much of the paper.

Yoshihiro Sato, listed at Mitate Hospital, is the only author of the paper who was not “honorary,” the managing editor of the journal confirmed. He and the same co-authors recently lost three other papers about preventing hip fractures for “concerns regarding data integrity” and authorship issues — one of those papers, published in JAMA, specified that Sato was responsible for the data. All four authors were also included in a retraction last year of a paper with “concerns about the underlying data;” there, too, Sato said his co-authors were named “for honorary reasons.”

Here’s the retraction notice for “Alendronate and vitamin D2 for prevention of hip fracture in Parkinson’s disease: A randomized controlled trial,” published in Movement Disorders:

Read the rest of this entry »

JAMA journals pull 3 papers by same authors for misconduct

with 2 comments

JAMAJAMA and another journal in its network have retracted three 2005 papers about preventing hip fractures, after an admission of scientific misconduct. 

All papers are being retracted over concerns about data integrity, and “inappropriate assignment of authorship.” Four of the authors — all based in Japan — have co-authored all of the three newly retracted papers, and also share authorship of a previous retraction from 2015

The JAMA paper was tagged with an Expression of Concern last year, regarding the “conduct, integrity, and scientific validity” of the paper. 

Here’s the retraction notice for the JAMA paper, “Effect of Folate and Mecobalamin on Hip Fractures in Patients With Stroke:” Read the rest of this entry »

Journals retracts three bone papers for duplication by same author

with 4 comments

1-s2.0-S0168365907X02700-cov150hA journal is Journals are retracting three papers after a biomaterials researcher duplicated his own work, sometimes using the same figures to describe different experiments.

Two of the papers are on bone regeneration; one is about targeting tumors. In addition to issues with figures, two one of the retraction notes explain that the papers contain “widespread plagiarism of text” from other papers by the researcher, Hossein Hosseinkhani.

Hosseinkhani is currently affiliated with the National Taiwan University of Science and Technology; when he did the work in the now retracted papers, published in 2004 and 2007, he was based at Kyoto University Hospital and then National Institute for Materials Science in Japan.

The Journal of Controlled Release published all three two of the papers. Here’s the retraction note for “Bone regeneration through controlled release of bone morphogenetic protein-2 from 3-D tissue engineered nano-scaffold,” which has been cited 118 times, according to Thomson Scientific’s Web of Knowledge.

Read the rest of this entry »